(Total Views: 36)
Posted On: 11/07/2025 12:24:13 PM
Post# of 39850
$BCTX presents strong preclinical data at SITC 2025: Bria-OTS+ rapidly activates both innate and adaptive immunity, producing potent, durable tumor-killing results. Lead programs Bria-BRES+ and Bria-PROS+ continue advancing. https://globenewswire.com/news-release/2025/1...-2025.html
(0)
(0)
